Janney Montgomery Scott
KRYS icon

Janney Montgomery Scott’s Krystal Biotech KRYS Stock Holding History

Janney Montgomery Scott’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Sell
2,170
-228
-10% -$60.7K ﹤0.01% 1972
2025
Q4 		$591K Sell
2,398
-182
-7% -$38.3K ﹤0.01% 2088
2025
Q3 		$455K Buy
2,580
+240
+10% +$35.9K ﹤0.01% 2209
2025
Q2 		$322K Sell
2,340
-43,595
-95% -$6.4M ﹤0.01% 2303
2025
Q1 		$8.28M Sell
45,935
-6,657
-13% -$1.12M 0.02% 596
2024
Q4 		$8.24M Buy
52,592
+15,545
+42% +$2.76M 0.02% 604
2024
Q3 		$6.74M Buy
37,047
+5,415
+17% +$1.04M 0.02% 664
2024
Q2 		$5.81M Buy
31,632
+13,789
+77% +$2.32M 0.02% 673
2024
Q1 		$3.17M Buy
+17,843
New +$2.48M 0.01% 939
2023
Q3 		– Sell
-3,320
Closed -$390K – 2686
2023
Q2 		$390K Buy
+3,320
New +$339K ﹤0.01% 2050

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott's KRYS Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Krystal Biotech (KRYS) stake by 9.5% in Q1 2026, selling an estimated $60.7K and leaving 2,170 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

Janney Montgomery Scott first reported a position in KRYS in Q2 2023 and has held it in 10 quarters since. The position peaked at $8.28M in Q1 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Janney Montgomery Scott held 2,170 shares of Krystal Biotech worth $561K as of Q1 2026.
  • Janney Montgomery Scott sold 228 Krystal Biotech shares in Q1 2026, an estimated $60.7K.
  • Krystal Biotech made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1972 holding.
  • Janney Montgomery Scott first reported a position in Krystal Biotech in Q2 2023 and has held it in 10 quarters since.
  • Janney Montgomery Scott's Krystal Biotech position peaked at $8.28M in Q1 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.